cardiovascular risks News
Most Popular cardiovascular risks Story
FDA expert wants Avandia withdrawn
The FDA's David Graham says that GSK's Avandia should be pulled from the market due to safety concerns. The safety Read more...
Latest Headlines
- July 31, 2007
- July 30, 2007
- December 12, 2006
- November 9, 2006
- November 5, 2006
- July 13, 2006
- May 17, 2006
- April 10, 2006
- March 22, 2006
- February 22, 2006
- February 1, 2006
- September 18, 2005
- August 22, 2005
- August 1, 2005
- July 19, 2005
- June 28, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
